Unusual Etiology of Acute Myocardial Infarction – Factor V Leiden Mutation
The genetic defect of coagulation factor V known as factor V Leiden produces a resistance to degradation of factor V by activated protein C (APC) and that will increase the risk of venous thromboembolism. The data on arterial thrombosis and acute myocardial infarction associated with APC resistance are still not clearly defined. We report a case of acute myocardial infarction in young patient with no cardiovascular risk factors and the etiology of the myocardial infarction was defined as acute arterial thrombosis associated with factor V Leiden defect, without any significant coronary lesions.
Sharifi M, Frohlich TG, Silverman IM. Myocardial infarction with angiographically normal coronary arteries. Chest. 1995;107:36-40.
Alpert JS. Myocardial infarction with angiographically normal coronary arteries. Arch Intern Med. 1994;154:265-9.
Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367:651.
Mannucci PM, Asselta R, Duga S, Guilla I, Sperafico M, Lotta L, Merlini PA, Peyvandi F, Kathriresan S, Ardissino D. The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease. J Thromb Haemost 2010; 8:2116.
Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood 2002; 100:3.
Mansourati J, Da Costa A, Munier S, Mercier B, Tardy B, Ferec C, Isaaz K, Blanc JJ. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 2000; 83:822.
Shewan L.G., Coats A.J.S., Henein M. Requirements for Ethical Publishing in Biomedical Journals. International Cardiovascular Forum Journal. 2015;2:2. http://dx.doi.org/10.17987/icfj.v2i1.4
Authors who publish with this journal agree to the following terms:
a. The authors will retain copyright under a Creative Commons Attribution License (CC-BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).